Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer

NCT00919880 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

148

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: carboplatin+ paclitaxel
DRUG: paclitaxel

Sponsor

Tao OUYANG